The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...
Monash University and Monash Health are collaborating on projects that aim to develop the first effective drug for two types of high cholesterol that until now have had no effective treatment. The ...
Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.
Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...
Lilly's drug is the only oral treatment in a field of several injectable therapies being tested to treat high Lp(a), a risk factor for heart disease that affects one in five individuals globally ...
Butter is high in saturated fats (derived from both animal fats and vegetable oils) and can be the culprit behind rising ...
Lilly’s drug is the only oral treatment in a field of several injectable therapies being tested to treat high Lp(a), a risk ...
Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.
An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk of heart attack, stroke, heart failure and death due to cardiovascular ...
When you've got hyperlipidemia—that's the fancy term for high cholesterol—those extra lipids begin clogging up your arteries. The Cleveland Clinic has broken it down: think of these lipids ...
Lifestyle factors such as poor diet, obesity, smoking, and excessive alcohol intake are known to contribute to high cholesterol levels. Dubbed the 'silent killer', high cholesterol often goes ...
the risks of heart disease are calculated. As a rule of thumb, less than 5.2 is low, 5.2-6.5 is average, 6.5-7.8 is moderately high and greater than 7.8 ...